PRVA Stock Recent News

Privia Health Group, Inc. shows growth in key business metrics and can unlock risk capital for equity investors this year. Q2 financials demonstrate top-line growth, gross margins, and critical unit economics. The company's asset-light business model drives economic value and supports an upside view on market value in my view.

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Parth Mehrotra - President and CEO David Mountcastle - CFO Robert Borchert - SVP, Investor & Corporate Communications Conference Call Participants Jailendra Singh - Truist Securities Lisa Gill - J.P. Morgan Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity Inc. Taji Phillips - Jefferies Group Jamie Perse - Goldman Sachs Jeff Garro - Stephens Inc. Andrew Mok - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Whit Mayo - SVB Securities Ryan Langston - TD Cowen Sandy Draper - Guggenheim Partners Ryan Daniels - William Blair Thomas Kelliher - RBC Capital Markets Operator Good day, and thank you for standing by.

Investors with an interest in Medical Info Systems stocks have likely encountered both GE HealthCare Technologies (GEHC) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?

ARLINGTON, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2023 before market open on Thursday, August 3, 2023.

ARLINGTON, Va., May 31, 2023 (GLOBE NEWSWIRE) --  Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team plans to participate in the following investor conferences:

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate Communications Shawn Morris - CEO Parth Mehrotra - President and COO David Mountcastle - CFO Conference Call Participants Lisa Gill - JPMorgan A.J. Rice - Credit Suisse Andrew Mok - UBS Gary Taylor - Cowen Whit Mayo - SVB Jessica Tassan - Piper Sandler David Larsen - BTIG Richard Close - Canaccord Jamie Perse - Goldman Sachs Joshua Raskin - Nephron Research Brian Tanquilut - Jefferies Adam Ron - Bank of America Jailendra Singh - Truist Jeff Garro - Stephens Ryan Daniels - William Blair Operator Good day, and thank you for standing by.

Privia Health (PRVA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago.